Regenerating matrix-based therapy for chronic wound healing: a prospective within-subject pilot study

Area of Science:

• Regenerative Medicine
• Wound Healing Research
• Biomaterials Science

Background:

• Chronic wounds pose a significant clinical challenge, often exhibiting delayed healing.
• Existing treatments have limitations in promoting complete wound closure and pain management.

Purpose of the Study:

• To evaluate the efficacy of a bioengineered skin-specific regenerating agent, CACIPLIQ20 (a heparan sulfate mimetic), in improving chronic wound healing.
• To assess the impact of CACIPLIQ20 on wound size reduction, pain levels, and overall patient and clinician satisfaction.

Main Methods:

• A prospective, within-subject study was conducted in an urban hospital setting.
• 16 participants with chronic wounds (pressure, diabetic, vascular, burn) were treated with CACIPLIQ20 soaked gauze applied twice weekly for 4 weeks, alongside standard care.
• Wound size was measured using the VERG digital system, and pain was assessed using visual analogue and wound pain scales.

Main Results:

• Twenty-two percent of wounds achieved complete healing within the treatment period.
• Significant reductions in wound size were observed at 4 weeks (15.2-18.1%) and 8 weeks (18-26%).
• Wound-related pain decreased significantly (60-70%), and patient/clinician satisfaction remained high.

Conclusions:

• Treatment with CACIPLIQ20 significantly improved chronic wound healing indicators, including size reduction and pain management.
• The heparan sulfate mimetic demonstrated potential as an effective therapeutic agent for chronic wounds.
• High levels of patient and clinician satisfaction suggest a positive clinical profile for CACIPLIQ20.